[go: up one dir, main page]

ZA200810703B - Compounds having a potentiating effect on the activity of ethionamide and uses thereof - Google Patents

Compounds having a potentiating effect on the activity of ethionamide and uses thereof

Info

Publication number
ZA200810703B
ZA200810703B ZA200810703A ZA200810703A ZA200810703B ZA 200810703 B ZA200810703 B ZA 200810703B ZA 200810703 A ZA200810703 A ZA 200810703A ZA 200810703 A ZA200810703 A ZA 200810703A ZA 200810703 B ZA200810703 B ZA 200810703B
Authority
ZA
South Africa
Prior art keywords
ethionamide
activity
compounds
potentiating effect
potentiating
Prior art date
Application number
ZA200810703A
Other languages
English (en)
Inventor
Benoit Deprez
Nicolas Willand
Bertrand Dirie
Patrick Toto
Vincent Villeret
Camille Locht
Alain Baulard
Original Assignee
Pasteur Institut
Centre Nat Rech Scient
Univ Lille 2
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut, Centre Nat Rech Scient, Univ Lille 2, Inst Nat Sante Rech Med filed Critical Pasteur Institut
Publication of ZA200810703B publication Critical patent/ZA200810703B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/472Non-condensed isoquinolines, e.g. papaverine
    • A61K31/4725Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • A61P31/06Antibacterial agents for tuberculosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • A61P31/08Antibacterial agents for leprosy
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA200810703A 2006-07-04 2008-12-19 Compounds having a potentiating effect on the activity of ethionamide and uses thereof ZA200810703B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0606088A FR2903405B1 (fr) 2006-07-04 2006-07-04 Composes a effet potentialisateur de l'activite de l'ethionamide et leurs applications

Publications (1)

Publication Number Publication Date
ZA200810703B true ZA200810703B (en) 2009-10-28

Family

ID=37775154

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200810703A ZA200810703B (en) 2006-07-04 2008-12-19 Compounds having a potentiating effect on the activity of ethionamide and uses thereof

Country Status (13)

Country Link
US (1) US8338599B2 (xx)
EP (1) EP2044064A1 (xx)
JP (1) JP2009541474A (xx)
KR (1) KR20090043506A (xx)
CN (1) CN101516876A (xx)
AP (1) AP2009004747A0 (xx)
AU (1) AU2007271013A1 (xx)
BR (1) BRPI0714225A2 (xx)
CA (1) CA2656502C (xx)
EA (1) EA200970081A1 (xx)
FR (1) FR2903405B1 (xx)
WO (1) WO2008003861A1 (xx)
ZA (1) ZA200810703B (xx)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009080432A2 (en) 2007-12-21 2009-07-02 Eth Zurich Composition for treatment of tuberculosis
GB0813740D0 (en) * 2008-07-28 2008-09-03 Angeletti P Ist Richerche Biologica Therapeutic compounds
JP5685247B2 (ja) * 2009-06-25 2015-03-18 バイオヴァーシス・アーゲーBioversys Ag 結核を処置するための組成物
GB0916608D0 (en) * 2009-09-22 2009-11-04 Angeletti P Ist Richerche Bio Therapeutic compounds
WO2012040170A2 (en) * 2010-09-20 2012-03-29 University Of Virginia Patent Foundation Compositions and methods for treating tuberculosis
US8962658B2 (en) 2011-10-25 2015-02-24 Universite De Droit Et De La Sante De Lille 2 Fluoralkylcarbonyl-oxadiazoles
EP2809668B1 (en) 2012-02-02 2017-04-12 Actelion Pharmaceuticals Ltd. 4-(benzoimidazol-2-yl)-thiazole compounds and related aza derivatives
FR3000064A1 (fr) 2012-12-21 2014-06-27 Univ Lille Ii Droit & Sante Composes de type spiroisoxazoline ayant une activite potentialisatrice de l'activite d'un antibiotique-composition et produit pharmaceutiques comprenant de tels composes
FR3000065A1 (fr) 2012-12-21 2014-06-27 Univ Lille Ii Droit & Sante Composes bicycliques ayant une activite potentialisatrice de l'activite d'un antibiotique actif contre les mycobacteries-composition et produit pharmaceutiques comprenant de tels composes
ES2671323T3 (es) 2013-07-22 2018-06-06 Idorsia Pharmaceuticals Ltd Derivados 1¿(piperazin¿1¿il)¿2¿([1,2,4]triazol¿1¿il)¿etanona
AR099789A1 (es) 2014-03-24 2016-08-17 Actelion Pharmaceuticals Ltd Derivados de 8-(piperazin-1-il)-1,2,3,4-tetrahidro-isoquinolina
AR103399A1 (es) 2015-01-15 2017-05-10 Actelion Pharmaceuticals Ltd Derivados de (r)-2-metil-piperazina como moduladores del receptor cxcr3
HRP20190024T1 (hr) 2015-01-15 2019-02-22 Idorsia Pharmaceuticals Ltd Derivati hidroksialkil-piperazina kao modulatori receptora cxcr3
HRP20211894T1 (hr) * 2017-08-16 2022-08-19 Glaxosmithkline Intellectual Property Development Limited Novi spojevi
US20200281202A1 (en) * 2017-09-08 2020-09-10 Pi Industries Ltd. Novel fungicidal heterocyclic compounds
CN108558858A (zh) * 2018-05-23 2018-09-21 成都师范学院 硝基呋喃类抗结核化合物
WO2020113094A1 (en) 2018-11-30 2020-06-04 Nuvation Bio Inc. Pyrrole and pyrazole compounds and methods of use thereof
CN116438174B (zh) * 2020-06-23 2025-10-31 南京艾美斐生物医药科技有限公司 化合物及其作为mif抑制剂的用途

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2275458A1 (fr) * 1974-06-21 1976-01-16 Aries Robert Analogues de la rifampicine portant un noyau oxadiazole
US6107313A (en) * 1998-10-02 2000-08-22 Combichem, Inc. Dopamine receptor antagonists
WO2001002375A1 (en) * 1999-07-01 2001-01-11 Chemrx Advanced Technologies, Inc. Process for synthesizing oxadiazoles
US20010049373A1 (en) * 2000-01-28 2001-12-06 Chalquest Richard R. Materials and methods for killing nematodes and nematode eggs
WO2003093297A2 (en) * 2002-05-03 2003-11-13 Exelixis, Inc. Protein kinase modulators and methods of use
JP2006502134A (ja) * 2002-08-09 2006-01-19 アストラゼネカ アクチボラグ 代謝調節型グルタミン酸受容体において活性を有する化合物
GB0325956D0 (en) * 2003-11-06 2003-12-10 Addex Pharmaceuticals Sa Novel compounds
JP4958560B2 (ja) * 2003-12-24 2012-06-20 プロシディオン・リミテッド Gpcr受容体作動薬としてのヘテロ環誘導体
EP1604989A1 (en) * 2004-06-08 2005-12-14 Santhera Pharmaceuticals (Deutschland) Aktiengesellschaft DPP-IV inhibitors
AU2005290081B2 (en) * 2004-08-23 2010-12-02 Merck Sharp & Dohme Corp. Inhibitors of Akt activity
TW200633990A (en) * 2004-11-18 2006-10-01 Takeda Pharmaceuticals Co Amide compound
TW200635587A (en) * 2004-12-01 2006-10-16 Kalypsys Inc Inducible nitric oxide synthase dimerization inhibitors
AU2005316826A1 (en) * 2004-12-15 2006-06-22 Merck Sharp & Dohme Corp. Inhibitors of Akt activity
US8193359B2 (en) * 2004-12-24 2012-06-05 Prosidion Limited G-protein coupled receptor agonists

Also Published As

Publication number Publication date
JP2009541474A (ja) 2009-11-26
US8338599B2 (en) 2012-12-25
US20110136823A1 (en) 2011-06-09
CA2656502C (fr) 2017-06-13
AP2009004747A0 (en) 2009-02-28
FR2903405B1 (fr) 2011-09-09
CN101516876A (zh) 2009-08-26
WO2008003861A1 (fr) 2008-01-10
KR20090043506A (ko) 2009-05-06
AU2007271013A1 (en) 2008-01-10
EP2044064A1 (fr) 2009-04-08
FR2903405A1 (fr) 2008-01-11
BRPI0714225A2 (pt) 2013-01-29
CA2656502A1 (fr) 2008-01-10
EA200970081A1 (ru) 2009-06-30

Similar Documents

Publication Publication Date Title
ZA200810703B (en) Compounds having a potentiating effect on the activity of ethionamide and uses thereof
IL198010A0 (en) Phenylpropionamide compounds and the use thereof
IL244442B (en) Compounds of converted acylanilides and their use
ZA200804932B (en) Compounds for the inhibition of integrins and use thereof
IL198301A0 (en) Thiazole and oxazole-substituted arylamides
ZA200903401B (en) The uses of the carboxy-amido-triazole compounds and salts thereof
IL187776A0 (en) Benzamide derivatives and uses related thereto
PT2853293T (pt) Compostos de tionínio e a sua utilização
GB0512940D0 (en) Compounds and their use
IL185223A0 (en) Compounds and uses thereof
EP2124908A4 (en) CONNECTIONS AND ITS USE
GB0611115D0 (en) Compounds and their use
GB0520743D0 (en) Compounds and their use
EP2099459A4 (en) COMPOUNDS AND USES THEREOF
IL197074A0 (en) Thiadiazole compound and use thereof
IL192820A0 (en) Novel compounds and use thereof
PL1902047T3 (pl) Związek karboksyamidowy i jego zastosowanie
ZA200710899B (en) Diaper fastener
EP2120957A4 (en) COMPOUNDS AND USES THEREOF
GB0608797D0 (en) Novel agents and the use thereof
ZA200804378B (en) Iminopropene compound and use thereof
GB0604519D0 (en) Compounds and uses 2
GB0604516D0 (en) Compounds and uses 3
AU2006906220A0 (en) Arsenoxide compounds and use thereof
GB0615557D0 (en) Compounds and Uses Thereof